1. Home
  2. WVE vs FA Comparison

WVE vs FA Comparison

Compare WVE & FA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$12.65

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo First Advantage Corporation

FA

First Advantage Corporation

HOLD

Current Price

$9.49

Market Cap

2.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
FA
Founded
2012
2003
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
WVE
FA
Price
$12.65
$9.49
Analyst Decision
Strong Buy
Buy
Analyst Count
16
4
Target Price
$30.44
$19.00
AVG Volume (30 Days)
3.2M
988.7K
Earning Date
03-03-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$109,230,000.00
$1,461,496,000.00
Revenue This Year
N/A
$85.19
Revenue Next Year
$16.10
$4.90
P/E Ratio
N/A
N/A
Revenue Growth
103.75
93.41
52 Week Low
$5.28
$9.42
52 Week High
$21.73
$20.28

Technical Indicators

Market Signals
Indicator
WVE
FA
Relative Strength Index (RSI) 41.05 22.13
Support Level $12.51 $12.65
Resistance Level $14.15 $13.66
Average True Range (ATR) 0.76 0.96
MACD -0.04 -0.34
Stochastic Oscillator 8.29 1.46

Price Performance

Historical Comparison
WVE
FA

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About FA First Advantage Corporation

First Advantage Corp is a provider of global software and data in the Human Resources technology industry. The company leverages proprietary technology and AI across its platforms, data, and APIs to deliver comprehensive background screening, digital identity, and verification solutions driven by innovation, automation, and customer success. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment. The group serves customers in over 200 countries and territories, modernising hiring and onboarding on a global scale.

Share on Social Networks: